[Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D009929:Organ Size; D012510:Sarcoma 180 / Q000188:drug therapy*; D013154:Spleen / Q000187:drug effects
D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide
Vergleichende Untersuchungen über die zytostatische Wirkung des neuen N-Lost-Derivats "IMET 3393" und Endoxan an drei experimentellen Mäusetumoren (Ehrlich-Aszites-Karzinom, Sarkom 180 solid, Leukämie LAJ I)